Philadelphia Marathon Returns November 2021 With Half the Runners Philadelphia has tentatively set the weekend of November 19-21, 2021, as the date, but said it could change if a Covid spike comes along.
Published May 11, 2021 •
Updated on May 11, 2021 at 11:29 am
TELEMUNDO 51
The Philadelphia Marathon is returning in November, but with a date that could change and with half the available slots to join the race.
City officials said Tuesday that the weekend of November 19-21, 2021 is earmarked as race weekend for the 2021 race. They cautioned, however, that the date could move if coronavirus infections start trending upward. Cold weather months are some of the worst for the spread of respiratory viruses like Covid-19.
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2021
News provided by
Share this article
Share this article
- Presented promising preliminary pharmacokinetic and clinical data on EPI-7386 in metastatic castration-resistant prostate cancer at 2021 AACR
- Raised approximately $150 million in a public offering
HOUSTON and VANCOUVER, BC, May 6, 2021 /PRNewswire/ - ESSA Pharma Inc. ( ESSA or the Company ) (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today provided a corporate update and reported financial results for the fiscal second quarter ended March 31, 2021. All references to $ in this release refer to United States dollars, unless otherwise indicated.
NANOBIOTIX Announces First Quarter Operational and Financial Updates
Expanded clinical data set supporting tumor agnostic potential of NBTXR3 in presentation of first results in rectal cancer at ASCO-GI 2021
Initiated new combination study evaluating NBTXR3 activated by radiation in combination with chemotherapy in esophageal cancer and reported new preclinical data in immunotherapy at AACR RSM 2021, providing further support for radioenhancer NBTXR3 as a therapeutic combination-agnostic that could prime adaptive immune response for local and systemic control
New collaboration agreement signed by subsidiary Curadigm with Sanofi evaluating novel Nanoprimer technology in gene therapy
Cash, cash equivalents, and short-term investments were €107.1 million at March 31, 2021, continuing to support robust development plans into the second quarter of 2023
April 20, 2021
UCLA In the News lists selected mentions of UCLA in the world’s news media. Some articles may require registration or a subscription to view. See more UCLA In the News.
The UCLA CarbonBuilt team, led by Gaurav Sant, a professor of civil and environmental engineering at the UCLA Samueli School of Engineering, won the prize in the competition’s track for technologies related to coal-fired power generation. By mitigating the carbon footprint of concrete, the team’s invention could eventually be a major step in the global battle against climate change, Sant said. (Also: Forbes and PA Media.)
Genprex Inc (NASDAQ:GNPX) CEO Rodney Varner tells Proactive its collaborators have presented positive preclinical data for the combination of REQORSA,.